Erratum: Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems (FASEB Journal DOI: 10.1096/fj.05-5227fje);Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems

FASEB Journal

Volumn 20, Issue 9, 2006, Pages 630-

  Fischer, Tobias W ^a,b   Sweatman, Trevor W ^a   Semak, Igor ^a,c   Sayre, Robert M ^a   Wortsman, Jacobo ^d   Slominski, Andrzej ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c BELARUSIAN STATE UNIVERSITY   (Belarus)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 hydroxymelatonin; 4 hydroxymelatonin; AFMK; Melatonin; Skin; UVR

Indexed keywords

6 HYDROXYMELATONIN; MELATONIN; ANTIINFECTIVE AGENT;

ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; RADIATION DOSE; ULTRAVIOLET B RADIATION; CELL LINE; DRUG EFFECT; METABOLISM; RADIATION EXPOSURE; RADIATION RESPONSE; TRANSPORT AT THE CELLULAR LEVEL; ULTRAVIOLET RADIATION;

ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; CELL LINE; CELL-FREE SYSTEM; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; KERATINOCYTES; MELATONIN; ULTRAVIOLET RAYS;

EID: 33845706850     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-5227err     Document Type: Erratum

References (79)

1. Arendt, J. (1988) Melatonin. Clin. Endocrinol. (Oxf) 29, 205-229
2. Lerner, A. B., Case, J. D., Takahashi, Y. (1958) Isolation of melatonin, a pineal factor that lightens melanocytes. J. Am. Chem. Soc. 80, 2587
3. Bubenik, G. A. (2002) Gastrointestinal melatonin: localization, function, and clinical relevance. Dig. Dis. Sci. 47, 2336-2348
4. Cahill, G. M., and Besharse, J. C. (1992) Light-sensitive melatonin synthesis by Xenopus photoreceptors after destruction of the inner retina. Vis. Neurosci. 8, 487-490
5. Tan, D. X., Manchester, L. C., Reiter, R. J., Qi, W. B., Zhang, M., Weintraub, S. T., Cabrera, J., Sainz, R. M., and Mayo, J. C. (1999) Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim. Biophys. Acta 1472, 206-214
6. Carrillo-Vico, A., Calvo, J. R., Abreu, P., Lardone, P. J., Garcia-Maurino, S., Reiter, R. J., and Guerrero, J. M. (2004) Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J. 18, 537-539
7. Itoh, M. T., Ishizuka, B., Kuribayashi, Y., Amemiya, A., and Sumi, Y. (1999) Melatonin, its precursors, and synthesizing enzyme activities in the human ovary. Mol. Hum. Reprod. 5, 402-408
8. Reiter, R. J., and Tan, D. X. (2002) Melatonin: an antioxidant in edible plants. Ann. N. Y. Acad. Sci. 957, 341-344
9. Slominski, A., Fischer, T. W., Zmijewski, M. A., Wortsman, J., Semak, I., Zbytek, B., Slominski, R. M., and Tobin, D. J. (2005) On the role of melatonin in skin physiology and pathology. Endocrine 27, 137-148
10. Slominski, A., Wortsman, J., and Tobin, D. J. (2005) The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J. 19, 176-194
11. Tan, D. X., Chen L. D., Poeggeler, B., Manchester, L. C., Reiter, R. J. (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1, 57-60
12. Tan, D. X., Manchester, L. C., Hardeland, R., Lopez-Burillo, S., Mayo, J. C., Sainz, R. M., and Reiter, R. J. (2003) Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J. Pineal. Res. 34, 75-78
13. Tan, D. X., Reiter, R. J., Manchester, L. C., Yan, M. T., El Sawi, M., Sainz, R. M., Mayo, J. C., Kohen, R., Allegra, M., and Hardeland, R. (2002) Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top. Med. Chem. 2, 181-197
14. Maestroni, G. J. (2001) The immunotherapeutic potential of melatonin. Expert. Opin. Investig. Drugs 10, 467-476
15. Reiter, R. J., Tan, D. X., Poeggeler, B., Menendez-Pelaez, A., Chen, L. D., and Saarela, S. (1994) Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann. N. Y. Acad. Sci. 719, 1-12
16. Karasek, M., and Reiter, R. J. (2002) Melatonin and aging. Neuroendocrinol. Lett. 23 Suppl. 1, 14-16
17. Karbownik, M. (2002) Potential anticarcinogenic action of melatonin and other antioxidants mediated by antioxidative mechanisms. Neuroendocrinol. Lett. 23 Suppl. 1, 39-44
18. Reiter, R. J., Tan, D. X., and Maldonado, M. D. (2005) Melatonin as an antioxidant: physiology versus pharmacology. J. Pineal. Res. 39, 215-216
19. Slominski, A., Pisarchik, A., Semak, I., Sweatman, T., Wortsman, J., Szczesniewski, A., Slugocki, G., McNulty, J., Kauser, S., Tobin, D. J., Jing, C., and Johansson, O. (2002) Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J. 16, 896-898
20. Slominski, A., Semak, I., Pisarchik, A., Sweatman, T., Szczesniewski, A., and Wortsman, J. (2002) Conversion of L-tryptophan to serotonin and melatonin in human melanoma cells. FEBS Lett. 511, 102-106
21. Slominski, A., Pisarchik, A., Semak, I., Sweatman, T., and Wortsman, J. (2003) Characterization of the serotoninergic system in the C57BL/6 mouse skin. Eur. J. Biochem. 270, 3335-3344
22. Slominski, A., Pisarchik, A., and Wortsman, J. (2004) Expression of genes coding melatonin and serotonin receptors in rodent skin. Biochim. Biophys. Acta 1680, 67-70
23. Slominski, A., Baker, J., Rosano, T. G., Guisti, L. W., Ermak, G., Grande, M., and Gaudet, S. J. (1996) Metabolism of serotonin to N-acetylserotonin, melatonin, and 5-methoxytryptamine in hamster skin culture. J. Biol. Chem. 271, 12281-12286
24. Schallreuter, K. U., Wood, J. M., Pittelkow, M. R., Gutlich, M., Lemke, K. R., Rodl, W., Swanson, N. N., Hitzemann, K., and Ziegler, I. (1994) Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263, 1444-1446
25. Hasse, S., Gibbons, N. C., Rokos, H., Marles, L. K., and Schallreuter, K. U. (2004) Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress. J. Invest. Dermatol. 122, 307-313
26. Slominski, A., Pisarchik, A., Johansson, O., Jing, C., Semak, I., Slugocki, G., and Wortsman, J. (2003) Tryptophan hydroxylase expression in human skin cells. Biochim. Biophys. Acta 1639, 80-86
27. Slominski, A., Pisarchik, A., Zbytek, B., Tobin, D. J., Kauser, S., and Wortsman, J. (2003) Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J. Cell. Physiol. 196, 144-153
28. Hipler, U. C., Fischer, T. W., and Elsner, P. (2003) HaCaT cell proliferation influenced by melatonin. Skin Pharmacol. Appl. Skin Physiol. 16, 379-385
29. Slominski, A., and Pruski, D. (1993) Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp. Cell Res. 206, 189-194
30. Kadekaro, A. L., Andrade, L. N. S., Floeter-Winter, L. M., Rollag, M. D., Virador, V., Vieira, W., and Castrucci, A. M. (2004) MT-1 melatonin receptor expression increases the antiproliferative effect of melatonin on S-91 murine melanoma cells. J. Pineal. Res. 36, 204-211
31. Berman, B. (2001) Basal cell carcinoma and actinic keratoses: patients' perceptions of their disease and current treatments. Int. J. Dermatol. 40, 573-576
32. Collins, G. L., Nickoonahand, N., and Morgan, M. B. (2004) Changing demographics and pathology of nonmelanoma skin cancer in the last 30 years. Semin. Cutan. Med. Surg. 23, 80-83
33. de Vries, E., Bray, F. I., Eggermont, A. M., Coebergh, J. W., and Registries., E. N. O. C. (2004) Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics. Eur. J. Cancer Prev. 13, 387-395
34. Fischer, T. W., Scholz, G., Knoll, B., Hipler, U. C., and Elsner, P. (2001) Melatonin reduces UV-induced reactive oxygen species in a dose-dependent manner in IL-3-stimulated leukocytes. J. Pineal Res. 31, 39-45
35. Fischer, T. W., Scholz, G., Knoll, B., Hipler, U. C., and Elsner, P. (2004) Melatonin suppresses reactive oxygen species induced by UV irradiation in leukocytes. J. Pineal. Res. 37, 107-112
36. Bangha, E., Elsner, P., and Kistler, G. S. (1997) Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5- methoxytryptamine). Influence of the application time point. Dermatology 195, 248-252
37. Dreher, F., Gabard, B., Schwindt, D. A., and Maibach, H. I. (1998) Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: a human study in vivo. Br. J. Dermatol. 139, 332-339
38. Fischer, T. W., Zbytek, B., Sayre, R. M., Apostolov, E. O., Basnakian, A. G., Sweatman, T. W., Wortsman, J., Elsner, P., and Slominski, A. (2006) Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J. Pineal. Res. 40, 18-26
39. Fischer, T. W., Greif, C., Fluhr, J. W., Wigger-Alberti, W., and Elsner, P. (2004) Percutaneous penetration of topically applied melatonin in a cream and an alcoholic solution. Skin Pharmacol. Physiol. 17, 190-194
40. Kim, Y. O., Chung, H. J., Chung, S. T., Kim, J. H., Park, J. H., Kil, K. S., and Cho, D. H. (1999) Phototoxicity of melatonin. Arch. Pharm. Res. 22, 143-150
41. Mayo, J. C., Sainz, R. M., Tan, D. X., Hardeland, R., Leon, J., Rodriguez, C., and Reiter, R. J. (2005) Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J. Neuroimmunol. 165, 139-149
42. Onuki, J., Almeida, E. A., Medeiros, M. H., and Di Mascio, P. (2005) Inhibition of 5-aminolevulinic acid-induced DNA damage by melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, quercetin or resveratrol. J. Pineal Res. 38, 107-115
43. Silva, S. O., Rodrigues, M. R., Ximenes, V. F., Bueno-da-Silva, A. E., Amarante-Mendes, G. P., and Campa, A. (2004) Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release. J. Neuroimmunol. 156, 146-152
44. Ressmeyer, A. R., Mayo, J. C., Zelosko, V., Sainz, R. M., Tan, D. X., Poeggeler, B., Antolin, I., Zsizsik, B. K., Reiter, R. J., and Hardeland, R. (2003) Antioxidant properties of the melatonin metabolite N1-acetyl-5- methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep. 8, 205-213
45. Maharaj, D. S., Anoopkumar-Dukie, S., Glass, B. D., Antunes, E. M., Lack, B., Walker, R. B., and Daya, S. (2002) The identification of the UV degradants of melatonin and their ability to scavenge free radicals. J. Pineal. Res. 32, 257-261
46. Tan, D. X., Manchester, L. C., Burkhardt, S., Sainz, R. M., Mayo, J. C., Kohen, R., Shohami, E., Huo, Y. S., Hardeland, R., and Reiter, R. J. (2001) N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J. 15, 2294-2296
47. Kelly, R. W., Amato, F., and Seamark, R. F. (1984) N-acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesis. Biochem. Biophys. Res. Commun. 121, 372-379
48. Silva, S. O., Rodrigues, M. R., Carvalho, S. R., Catalani, L. H., Campa, A., and Ximenes, V. F. (2004) Oxidation of melatonin and its catabolites, N1-acetyl-N2 -formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leukocytes. J. Pineal Res. 37, 171-175
49. Semak, I., Naumova, M., Korik, E., Terekhovich, V., Wortsman, J., and Slominski, A. (2005) A novel metabolic pathway of melatonin: oxidation by cytochrome c. Biochemistry 44, 9300-9307
50. Ma, X., Idle, J. R., Krausz, K. W., and Gonzalez, F. J. (2005) Metabolism of melatonin by human cytochromes p450. Drug Metab. Dispos. 33, 489-494
51. Lerner, A. B., and Nordlund, J. J. (1978) Melatonin: clinical pharmacology. J. Neural. Transm. Suppl., 13, 339-347
52. Rozov, S. V., Filatova, E. V., Orlov, A. A., Volkova, A. V., Zhloba, A. R., Blashko, E. L., and Pozdeyev, N. V. (2003) N1-acetyl-N2-formyl-5- methoxykynuramine is a product of melatonin oxidation in rats. J. Pineal Res. 35, 245-250
53. Hardeland, R., Reiter, R. J., Poeggeler, B., and Tan, D. X. (1993) The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci. Biobehav. Rev. 17, 347-357
54. de Almeida, E. A., Martinez, G. R., Klitzke, C. F., de Medeiros, M. H., and Di Mascio, P. (2003) Oxidation of melatonin by singlet molecular oxygen (O2(1deltag)) produces N1-acetyl-N2-formyl-5-methoxykynurenine. J. Pineal Res. 35, 131-137
55. Almeida, E. A., Klitzke, C. F., Martinez, G. R., Medeiros, M. H., and Di Mascio, P. (2004) Synthesis of internal labeled standards of melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine for their quantification using an on-line liquid chromatography-electrospray tandem mass spectrometry system. J. Pineal Res. 36, 64-71
56. Schallreuter, K. U., and Wood, J. M. (2001) Thioredoxin reductase - its role in epidermal redox status. J. Photochem. Photobiol. B 64, 179-184
57. Tan, D. X., Manchester, L. C., Reiter, R. J., Plummer, B. F., Limson, J., Weintraub, S. T., and Qi, W. (2000) Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic. Biol. Med. 29, 1177-1185
58. Hardeland, R., Pandi-Perumal, S. R., and Cardinali, D. P. (2005) Melatonin. Int. J. Biochem. Cell Biol. DOI:10.1016/jbiocel.2005.1008.1020
59. Tesoriere, L., Avellone, G., Ceraulo, L., D'Arpa, D., Allegra, M., and Livrea, M. A. (2001) Oxidation of melatonin by oxoferryl hemoglobin: a mechanistic study. Free Radic. Res. 35, 633-642
60. Ximenes, V. F., de, O. S. S., Rodrigues, M. R., Catalani, L. H., Maghzal, G. J., Kettle, A. J., and Campa, A. (2005) Superoxide-dependent oxidation of melatonin by myeloperoxidase. J. Biol. Chem.
61. Horstman, J. A., Wrona, M. Z., and Dryhurst, G. (2002) Further insights into the reaction of melatonin with hydroxyl radical. Bioorg. Chem. 30, 371-382
62. Dellegar, S. M., Murphy, S. A., Bourne, A. E., DiCesare, J. C., and Purser, G. H. (1999) Identification of the factors affecting the rate of deactivation of hypochlorous acid by melatonin. Biochem. Biophys. Res. Commun. 257, 431-439
63. Wong, P. S., Yoshioka, K., Xie, F., and Kissinger, P. T. (1999) In vivo microdialysis/liquid chromatography/tandem mass spectrometry for the on-line monitoring of melatonin in rat. Rapid Commun. Mass Spectrom. 13, 407-411
64. Vakkuri, O., Tervo, J., Luttinen, R., Ruotsalainen, H., Rahkamaa, E., and Leppaluoto, J. (1987) A cyclic isomer of 2-hydroxymelatonin: a novel metabolite of melatonin. Endocrinology 120, 2453-2459
65. Stasica, P., Paneth, P., and Rosiak, J. M. (2000) Hydroxyl radical reaction with melatonin molecule: a computational study. J. Pineal Res. 29, 125-127
66. Lisby, S., Gniadecki, R., and Wulf, H. C. (2005) UV-induced DNA damage in human keratinocytes: quantitation and correlation with long-term survival. Exp. Dermatol. 14, 349-355
67. Schwarz, A., Stander, S., Berneburg, M., Bohm, M., Kulms, D., van Steeg, H., Grosse-Heitmeyer, K., Krutmann, J., and Schwarz, T. (2002) Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat. Cell Biol. 4, 26-31
68. Krutmann, J. (2001) The role of UVA rays in skin aging. Eur. J. Dermatol. 11, 170-171
69. Costa, E. J., Lopes, R. H., and Lamy-Freund, M. T. (1995) Permeability of pure lipid bilayers to melatonin. J. Pineal Res. 19, 123-126
70. Nickel, A., and Wohlrab, W. (2000) Melatonin protects human keratinocytes from UVB irradiation by light absorption. Arch. Dermatol. Res. 292, 366-368
71. Tan, D. X., Manchester, L. C., Reiter, R. J., Qi, W., Hanes, M. A., and Farley, N. J. (1999) High physiological levels of melatonin in the bile of mammals. Life Sci. 65, 2523-2529
72. Skinner, D. C., and Malpaux, B. (1999) High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 140, 4399-4405
73. Conti, A., Conconi, S., Hertens, E., Skwarlo-Sonta, K., Markowska, M., and Maestroni, J. M. (2000) Evidence for melatonin synthesis in mouse and human bone marrow cells. J. Pineal Res. 28, 193-202
74. Bubenik, G. A., Hacker, R. R., Brown, G. M., and Bartos, L. (1999) Melatonin concentrations in the luminal fluid, mucosa, and muscularis of the bovine and porcine gastrointestinal tract. J. Pineal Res. 26, 56-63
75. Finocchiaro, L. M., Nahmod, V. E., and Launay, J. M. (1991) Melatonin biosynthesis and metabolism in peripheral blood mononuclear leucocytes. Biochem. J. 280(Pt 3), 727-731
76. Iuvone, P. M., Tosini, G., Pozdeyev, N., Haque, R., Klein, D. C., and Chaurasia, S. S. (2005) Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina. Prog. Retin. Eye Res. 24, 433-456
77. Reiter, R. J., and Tan, D. X. (2003) What constitutes a physiological concentration of melatonin? J. Pineal Res. 34, 79-80
78. Slominski, A., Chassalevris, N., Mazurkiewicz, J., Maurer, M., and Paus, R. (1994) Murine skin as a target for melatonin bioregulation. Exp. Dermatol. 3, 45-50
79. Kobayashi, H., Kromminga, A., Dunlop, T. W., Tychsen, B., Conrad, F., Suzuki, N., Memezawa, A., Bettermann, A., Aiba, S., Carlberg, C., and Paus, R. (2005) A role of melatonin in neuroectodermal-mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors. FASEB J. 19, 1710-1712